A detailed history of Daiwa Securities Group Inc. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 593 shares of OCUL stock, worth $5,882. This represents 0.0% of its overall portfolio holdings.

Number of Shares
593
Previous 407 45.7%
Holding current value
$5,882
Previous $3,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$6.45 - $9.23 $1,199 - $1,716
186 Added 45.7%
593 $5,000
Q1 2024

May 02, 2024

BUY
$3.85 - $10.93 $558 - $1,584
145 Added 55.34%
407 $4,000
Q3 2021

Nov 05, 2021

BUY
$9.7 - $14.34 $1,241 - $1,835
128 Added 95.52%
262 $3,000
Q4 2020

Feb 04, 2021

BUY
$7.91 - $22.95 $1,059 - $3,075
134 New
134 $3,000
Q4 2019

Jan 31, 2020

SELL
$2.57 - $4.73 $688 - $1,267
-268 Closed
0 $0
Q1 2019

Apr 26, 2019

BUY
$3.51 - $4.77 $940 - $1,278
268 New
268 $1,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $764M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.